We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
+37.76%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$4.89B
AUM Growth
+$717M
Cap. Flow
-$266M
Cap. Flow %
-5.43%
Top 10 Hldgs %
40.48%
Holding
126
New
22
Increased
22
Reduced
35
Closed
16

Top Buys

1
PFE icon
Pfizer
PFE
+$41.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$37.3M
3
ELV icon
Elevance Health
ELV
+$33.5M
4
HELP
Cybin Inc
HELP
+$24.7M
5
BRKR icon
Bruker
BRKR
+$23.5M

Top Sells

1
TERN
Terns Pharmaceuticals
TERN
+$125M
2
RNAM
Avidity Biosciences
RNAM
+$65.8M
3
EXAS
Exact Sciences
EXAS
+$51.6M
4
AXSM icon
Axsome Therapeutics
AXSM
+$38.9M
5
SIBN icon
SI-BONE Inc
SIBN
+$38M

Sector Composition

1 Healthcare 99.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
101
PTC Therapeutics
PTCT
$6.54B
$1.76M 0.04%
+23,200
New +$1.69M
MPLT
102
MapLight Therapeutics
MPLT
$1.69B
$952K 0.02%
+56,000
New +$938K
TRAW icon
103
Traws Pharma
TRAW
$9.97M
$684K 0.01%
605,531
– –
ABT icon
104
Abbott
ABT
$155B
– –
0
– –
AKRO
105
DELISTED
Akero Therapeutics
AKRO
– –
-526,200
Closed -$25M
AMLX icon
106
Amylyx Pharmaceuticals
AMLX
$1.98B
– –
-750,600
Closed -$10.2M
ATAI icon
107
AtaiBeckley Inc
ATAI
$1.97B
– –
-347,000
Closed -$1.84M
AZN icon
108
AstraZeneca
AZN
$261B
– –
0
– –
IMTX icon
109
Immatics
IMTX
$1.29B
– –
-466,601
Closed -$3.98M
ITGR icon
110
Integer Holdings
ITGR
$3.24B
– –
-290,000
Closed -$30M
KRRO icon
111
Korro Bio
KRRO
$188M
– –
-32,400
Closed -$1.55M
KZR
112
DELISTED
Kezar Life Sciences
KZR
– –
-192,700
Closed -$752K
LYEL icon
113
Lyell Immunopharma
LYEL
$349M
– –
-51,727
Closed -$840K
MIST icon
114
Milestone Pharmaceuticals
MIST
$158M
– –
-3,221,828
Closed -$6.44M
MURA
115
DELISTED
Mural Oncology
MURA
– –
-588,800
Closed -$1.22M
PASG icon
116
Passage Bio
PASG
$15.8M
– –
-59,046
Closed -$474K
SCPH
117
DELISTED
scPharmaceuticals
SCPH
– –
-6,059,528
Closed -$34.4M
SIBN icon
118
SI-BONE Inc
SIBN
$765M
– –
-2,578,979
Closed -$38M
SRRK icon
119
Scholar Rock
SRRK
$6.48B
– –
0
– –
TGTX icon
120
TG Therapeutics
TGTX
$8.64B
– –
0
– –
VSTM icon
121
Verastem
VSTM
$504M
– –
-887,561
Closed -$7.84M
XERS icon
122
Xeris Biopharma Holdings
XERS
$1.5B
– –
-80,420
Closed -$655K
DHAI
123
DELISTED
DIH Holdings US
DHAI
– –
-76,600
Closed -$358K
1 2 3 4
5

Similar funds

CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $4.61B AUM 25.58% 1-Year Est. Return